What do the labels say about a missed semaglutide dose?

How late a weekly dose can be taken
LabelMissed weekly dose
Ozempic, USGiven as soon as possible within 5 days, skipped after that1
Ozempic, EuropeWithin 5 days, skipped after that4
Wegovy, USTaken if the next dose is more than 2 days (48 hours) away, skipped if less2
Wegovy, EuropeWithin 5 days, skipped after that3
Zepbound, USWithin 4 days (96 hours), skipped after that5
Mounjaro, USWithin 4 days (96 hours), skipped after that6
Mounjaro, EuropeTaken if 4 days or less since it was due, skipped if more7

The US Ozempic label gives 5 days to take a missed dose and says to skip it after that, while the US Wegovy label asks whether the next dose is more than 2 days away.12

How late a weekly dose can be taken

The same molecule carries a 2-day rule on the US Wegovy label, counted to the next scheduled dose, and a 5-day rule on the US Ozempic label and the European Wegovy and Ozempic texts, counted from the missed dose.2134

The table is set at the top of the page

The tirzepatide labels give 4 days where the Ozempic labels give 5.56714

The European Wegovy and Ozempic leaflets say not to use a double dose to make up for a forgotten one.34 The Zepbound and Mounjaro US texts say not to take 2 doses within 3 days of each other, and the European Mounjaro text sets the minimum time between two doses at 3 days.567

Several missed weeks

The US Wegovy label says that after 2 or more consecutive missed injections, dose escalation is restarted at a lower dosage to reduce the risk of gastrointestinal adverse reactions.2 Its patient instructions tell people who miss 2 or more consecutive weeks to contact their healthcare provider about restarting.2 The European Wegovy text says a reduced starting dose for re-initiation is to be considered if more doses are missed, and gives no number of doses.3 The Zepbound and Mounjaro US labels, the European Mounjaro text and both Ozempic labels give no rule for several missed doses.

Side effects and dose escalation

The European Wegovy text lists gastrointestinal disorders including nausea as the most frequently reported adverse reactions.3 The US Wegovy label says to follow its dose escalation schedule to reduce the risk of gastrointestinal adverse reactions.2 Reactions by missed-dose status are not reported in any label or trial found; the US Wegovy label's gastrointestinal figures cover the whole trial population.

Frequently asked questions

Can the injection day be changed after a missed dose?

The US Ozempic and Wegovy labels allow a change of weekly day when the two doses are at least 2 days apart.12 The US Zepbound label sets that gap at 3 days.5 The US Mounjaro label also sets it at 3 days (72 hours), and the European Wegovy, Ozempic and Mounjaro texts set it at 3 days, given as more than 72 hours in the Wegovy and Ozempic texts.6347

What does the oral semaglutide label say about a missed tablet?

The US label for Rybelsus and Ozempic tablets says to skip a missed tablet and go back to the regular schedule.8 The US Wegovy label gives the same rule for Wegovy tablets, with the next one taken the following day.2

Why does the half-life matter for a late dose?

The US Ozempic label gives semaglutide a half-life of approximately 1 week, with the drug present in the circulation for about 5 weeks after the last dose.1 The US Zepbound label gives tirzepatide an elimination half-life of approximately 5-6 days in people with overweight or obesity.5 The US Mounjaro label gives tirzepatide an elimination half-life of approximately 5 days.6

What about CJC-1295 and testosterone missed doses?

DailyMed lists no label for CJC-1295, so no missed-dose rule is given for it. The Depo-Testosterone and Xyosted labels contain no missed-dose, skipped-dose or forgotten-dose instruction.

References

  1. Novo Nordisk (DailyMed). OZEMPIC (semaglutide) injection, US prescribing information. 2026. dailymed.nlm.nih.gov
  2. Novo Nordisk (DailyMed). WEGOVY (semaglutide) injection and tablets, US prescribing information. 2026. dailymed.nlm.nih.gov
  3. European Medicines Agency. Wegovy, European product information (summary of product characteristics and package leaflet). ema.europa.eu
  4. European Medicines Agency. Ozempic, European product information (summary of product characteristics and package leaflet). ema.europa.eu
  5. Eli Lilly (DailyMed). ZEPBOUND (tirzepatide) injection, US prescribing information. 2026. dailymed.nlm.nih.gov
  6. Eli Lilly (DailyMed). MOUNJARO (tirzepatide) injection, US prescribing information. 2026. dailymed.nlm.nih.gov
  7. European Medicines Agency. Mounjaro, European product information (summary of product characteristics and package leaflet). ema.europa.eu
  8. Novo Nordisk (DailyMed). RYBELSUS and OZEMPIC tablets (oral semaglutide), US prescribing information. 2026. dailymed.nlm.nih.gov